FDA Inspection 1249561 — Lawrence J. Singerman, MD

Lawrence J. Singerman, MD — FEI 3031271450

The FDA completed an inspection of Lawrence J. Singerman, MD on Aug 23, 2024 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 23, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Cleveland, OH (United States)

Additional Details

Clinical Investigator (CI)